Abbott Wins FDA Approval for Device Treating Heart-Valve Replacement Leaks

Abbott Laboratories said the U.S. Food and Drug Administration (FDA) approved a new device to treat leaks that can occur after heart valve replacement.

The company said the device is the first and only technology in the U.S. designed to address these leaks without another open-heart surgery. The minimally invasive option is intended for patients at high risk for repeat surgery and expands Abbott’s structural heart portfolio.